JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has commenced commercial launch of Quetiapine Fumarate Tablets, the Company’s generic version of AstraZeneca’s schizophrenia treatment, Seroquel® Tablets. The brand product had annual sales of approximately $4.6 billion in the United States, based on IMS sales data.
